Hollsteen
← Apple

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $128.3B · 10-Q 0001193125-16-439878 filed Jan 27, 2016Equity incl. NCI · Q2 FY2016: $130.5B · 10-Q 0001193125-16-559625 filed Apr 27, 2016Equity incl. NCI · Q3 FY2016: $126.5B · 10-Q 0001628280-16-017809 filed Jul 27, 2016Equity incl. NCI · Q4 FY2016: $128.2B · 10-K 0001628280-16-020309 filed Oct 26, 2016Equity incl. NCI · Q1 FY2017: $132.4B · 10-Q 0001628280-17-000717 filed Feb 1, 2017Equity incl. NCI · Q2 FY2017: $134.1B · 10-Q 0001628280-17-004790 filed May 3, 2017Equity incl. NCI · Q3 FY2017: $132.4B · 10-Q 0000320193-17-000009 filed Aug 2, 2017Equity incl. NCI · Q4 FY2017: $134.0B · 10-K 0000320193-17-000070 filed Nov 3, 2017Equity incl. NCI · Q1 FY2018: $140.2B · 10-Q 0000320193-18-000007 filed Feb 2, 2018Equity incl. NCI · Q2 FY2018: $126.9B · 10-Q 0000320193-18-000070 filed May 2, 2018Equity incl. NCI · Q3 FY2018: $114.9B · 10-Q 0000320193-18-000100 filed Aug 1, 2018Equity incl. NCI · Q4 FY2018: $107.1B · 10-K 0000320193-18-000145 filed Nov 5, 2018Equity incl. NCI · Q1 FY2019: $117.9B · 10-Q 0000320193-19-000010 filed Jan 30, 2019Equity incl. NCI · Q2 FY2019: $105.9B · 10-Q 0000320193-19-000066 filed May 1, 2019Equity incl. NCI · Q3 FY2019: $96.5B · 10-Q 0000320193-19-000076 filed Jul 31, 2019Equity incl. NCI · Q4 FY2019: $90.5B · 10-K 0000320193-19-000119 filed Oct 31, 2019Equity incl. NCI · Q1 FY2020: $89.5B · 10-Q 0000320193-20-000010 filed Jan 29, 2020Equity incl. NCI · Q2 FY2020: $78.4B · 10-Q 0000320193-20-000052 filed May 1, 2020Equity incl. NCI · Q3 FY2020: $72.3B · 10-Q 0000320193-20-000062 filed Jul 31, 2020Equity incl. NCI · Q4 FY2020: $65.3B · 10-K 0000320193-20-000096 filed Oct 30, 2020Equity incl. NCI · Q1 FY2021: $66.2B · 10-Q 0000320193-21-000010 filed Jan 28, 2021Equity incl. NCI · Q2 FY2021: $69.2B · 10-Q 0000320193-21-000056 filed Apr 29, 2021Equity incl. NCI · Q3 FY2021: $64.3B · 10-Q 0000320193-21-000065 filed Jul 28, 2021Equity incl. NCI · Q4 FY2021: $63.1B · 10-K 0000320193-21-000105 filed Oct 29, 2021Equity incl. NCI · Q1 FY2022: $71.9B · 10-Q 0000320193-22-000007 filed Jan 28, 2022Equity incl. NCI · Q2 FY2022: $67.4B · 10-Q 0000320193-22-000059 filed Apr 29, 2022Equity incl. NCI · Q3 FY2022: $58.1B · 10-Q 0000320193-22-000070 filed Jul 29, 2022Equity incl. NCI · Q4 FY2022: $50.7B · 10-K 0000320193-22-000108 filed Oct 28, 2022Equity incl. NCI · Q1 FY2023: $56.7B · 10-Q 0000320193-23-000006 filed Feb 3, 2023Equity incl. NCI · Q2 FY2023: $62.2B · 10-Q 0000320193-23-000064 filed May 5, 2023Equity incl. NCI · Q3 FY2023: $60.3B · 10-Q 0000320193-23-000077 filed Aug 4, 2023Equity incl. NCI · Q4 FY2023: $62.1B · 10-K 0000320193-23-000106 filed Nov 3, 2023Equity incl. NCI · Q1 FY2024: $74.1B · 10-Q 0000320193-24-000006 filed Feb 2, 2024Equity incl. NCI · Q2 FY2024: $74.2B · 10-Q 0000320193-24-000069 filed May 3, 2024Equity incl. NCI · Q3 FY2024: $66.7B · 10-Q 0000320193-24-000081 filed Aug 2, 2024Equity incl. NCI · Q4 FY2024: $57.0B · 10-K 0000320193-24-000123 filed Nov 1, 2024Equity incl. NCI · Q1 FY2025: $66.8B · 10-Q 0000320193-25-000008 filed Jan 31, 2025Equity incl. NCI · Q2 FY2025: $66.8B · 10-Q 0000320193-25-000057 filed May 2, 2025Equity incl. NCI · Q3 FY2025: $65.8B · 10-Q 0000320193-25-000073 filed Aug 1, 2025Equity incl. NCI · Q4 FY2025: $73.7B · 10-K 0000320193-25-000079 filed Oct 31, 2025Equity incl. NCI · Q1 FY2026: $88.2B · 10-Q 0000320193-26-000006 filed Jan 30, 2026Equity incl. NCI · Q2 FY2026: $106.5B · 10-Q 0000320193-26-000013 filed May 1, 2026Equity incl. NCI · Q3 FY2026: $107.5B · 10-Q 0000320193-26-000020 filed Jul 31, 202667.4107.5128.3140.2Q1 FY2016Q3 FY2026Q2 FY2022
$BEquity incl. NCI · Q2 FY2021: $69.2B · 10-Q 0000320193-21-000056 filed Apr 29, 2021Equity incl. NCI · Q3 FY2021: $64.3B · 10-Q 0000320193-21-000065 filed Jul 28, 2021Equity incl. NCI · Q4 FY2021: $63.1B · 10-K 0000320193-21-000105 filed Oct 29, 2021Equity incl. NCI · Q1 FY2022: $71.9B · 10-Q 0000320193-22-000007 filed Jan 28, 2022Equity incl. NCI · Q2 FY2022: $67.4B · 10-Q 0000320193-22-000059 filed Apr 29, 2022Equity incl. NCI · Q3 FY2022: $58.1B · 10-Q 0000320193-22-000070 filed Jul 29, 2022Equity incl. NCI · Q4 FY2022: $50.7B · 10-K 0000320193-22-000108 filed Oct 28, 2022Equity incl. NCI · Q1 FY2023: $56.7B · 10-Q 0000320193-23-000006 filed Feb 3, 202367.456.769.271.9Q2 FY2021Q1 FY2023Q2 FY2022
Q2 FY2022
67.4$B
All values (43)
PeriodValue ($B)Status
Q3 FY2026107.5reported
Q2 FY2026106.5reported
Q1 FY202688.2reported
Q4 FY202573.7reported
Q3 FY202565.8reported
Q2 FY202566.8reported
Q1 FY202566.8reported
Q4 FY202457.0reported
Q3 FY202466.7reported
Q2 FY202474.2reported
Q1 FY202474.1reported
Q4 FY202362.1reported
Q3 FY202360.3reported
Q2 FY202362.2reported
Q1 FY202356.7reported
Q4 FY202250.7reported
Q3 FY202258.1reported
Q2 FY202267.4reported
Q1 FY202271.9reported
Q4 FY202163.1reported
Q3 FY202164.3reported
Q2 FY202169.2reported
Q1 FY202166.2reported
Q4 FY202065.3reported
Q3 FY202072.3reported
Q2 FY202078.4reported
Q1 FY202089.5reported
Q4 FY201990.5reported
Q3 FY201996.5reported
Q2 FY2019105.9reported
Q1 FY2019117.9reported
Q4 FY2018107.1reported
Q3 FY2018114.9reported
Q2 FY2018126.9reported
Q1 FY2018140.2reported
Q4 FY2017134.0reported
Q3 FY2017132.4reported
Q2 FY2017134.1reported
Q1 FY2017132.4reported
Q4 FY2016128.2reported
Q3 FY2016126.5reported
Q2 FY2016130.5reported
Q1 FY2016128.3reported

CSV with all sources · Technical ID: equity_total

More metrics for Apple

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$67.4B
Period
Q2 FY2022, ended Mar 26, 2022 · as of Mar 26, 2022 (balance as of date, not a sum)
Source
10-Q, filed Apr 29, 2022 · 0000320193-22-000059
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$67.4BApr 29, 202210-Q 0000320193-22-000059reported · confidence 1. · current